Tokyo Tape
Sign in
← Nihon Chouzai

Quarterly report · Q3

3341.TEDINET S100SVMG
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥254.1bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥313.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥232.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥6.5bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥5.8bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥6.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥7.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥6.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥7.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥4.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥194.4bnat 2023-12-31Cons.Assets
Total assets¥185.3bnat 2023-03-31Cons.Assets
Total assets¥187.6bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥134.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥128.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥59.5bnat 2023-12-31Cons.Net assets
Net assets / equity¥56.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥56.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥16.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥23.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥125.992023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.552023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥148.922022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥143.232022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio30.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥10.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥10.0bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥5.4bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥225.6bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥225.6bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥10.6bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥7.4bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥7.3bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥35m
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥795m
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥31.2bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥21.2bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9.9bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥555m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥264.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥254.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥10.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥12.0bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥10.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥10.5bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥4.9bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥208.1bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥208.1bn
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥10.6bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥10m
jpcrp040300-q3r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥602m
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥29.3bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥10.4bn
jpcrp040300-q3r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2022-04-01 → 2022-12-31−¥456m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥243.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥232.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥10.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥10.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 356
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member2061600
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0643
Number of shares held in own name treasury shares etcCurrentQuarterInstant2061600
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant2061600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0643
Cash and depositsPrior1YearInstant23770000000JPY
Cash and depositsCurrentQuarterInstant16926000000JPY
Notes receivable tradePrior1YearInstant70000000JPY
Notes receivable tradeCurrentQuarterInstant45000000JPY
Accounts receivable trade and contract assets caPrior1YearInstant21246000000JPY
Accounts receivable trade and contract assets caCurrentQuarterInstant23126000000JPY
Electronically recorded monetary claims operating caPrior1YearInstant437000000JPY
Electronically recorded monetary claims operating caCurrentQuarterInstant226000000JPY
Merchandise and finished goodsPrior1YearInstant28416000000JPY
Merchandise and finished goodsCurrentQuarterInstant34565000000JPY
Work in processPrior1YearInstant1742000000JPY
Work in processCurrentQuarterInstant1980000000JPY
Raw materials and suppliesPrior1YearInstant6021000000JPY
Raw materials and suppliesCurrentQuarterInstant6789000000JPY
Other caPrior1YearInstant4022000000JPY
Other caCurrentQuarterInstant4656000000JPY
Allowance for doubtful accounts caPrior1YearInstant-6000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-6000000JPY
Current assetsPrior1YearInstant85720000000JPY
Current assetsCurrentQuarterInstant88309000000JPY
Buildings and structures netPrior1YearInstant28361000000JPY
Buildings and structures netCurrentQuarterInstant29517000000JPY
LandPrior1YearInstant13377000000JPY
LandCurrentQuarterInstant13339000000JPY
Construction in progressPrior1YearInstant1828000000JPY
Construction in progressCurrentQuarterInstant2513000000JPY
Other net ppePrior1YearInstant17867000000JPY
Other net ppeCurrentQuarterInstant17375000000JPY
Property plant and equipmentPrior1YearInstant61435000000JPY
Property plant and equipmentCurrentQuarterInstant62746000000JPY
GoodwillPrior1YearInstant14195000000JPY
GoodwillCurrentQuarterInstant13174000000JPY
Other iaPrior1YearInstant5377000000JPY
Other iaCurrentQuarterInstant7931000000JPY
Intangible assetsPrior1YearInstant19573000000JPY
Intangible assetsCurrentQuarterInstant21105000000JPY
Investment securitiesPrior1YearInstant16000000JPY
Investment securitiesCurrentQuarterInstant16000000JPY
Lease and guarantee depositsPrior1YearInstant9160000000JPY
Lease and guarantee depositsCurrentQuarterInstant11932000000JPY
Other ioaPrior1YearInstant9391000000JPY
Other ioaCurrentQuarterInstant10254000000JPY
Investments and other assetsPrior1YearInstant18568000000JPY
Investments and other assetsCurrentQuarterInstant22203000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass